Clinical trials

Pharmacies compounding Semaglutide raises concerns

by
Pharmacies compounding Semaglutide raises concerns

The US Food and Drug Administration (FDA) recently warned two online suppliers to stop manufacturing unapproved versions of semaglutide (marketed as Ozempic for type 2 diabetes). 2; Wegovy for obesity) and tirzepatide (Mounjaro). With ongoing shortages of these two popular drugs, compounded versions have become popular. According to the FDA, compounding pharmacies are allowed to … Read more

Europe’s resilience depends on its ability to innovate

by
Europe's resilience depends on its ability to innovate

In the face of continuing global geopolitical instability, Europe is increasingly paying attention to its sovereignty, security and resilience. The availability of vital medicines and vaccines is central to Europe’s health preparedness. As governments across Europe rebuild and learn from the pandemic, policies that can build health resilience and strengthen health systems are coming into … Read more